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Abstract 
Antibiotic resistance carries a fitness cost that must be overcome in order for resistance to persist over 1 
the long term. Compensatory mutations that recover the functional defects associated with resistance 2 
mutations have been argued to play a key role in overcoming the cost of resistance, but compensatory 3 
mutations are expected to be rare relative to generally beneficial mutations that increase fitness 4 
irrespective of antibiotic resistance. Given this asymmetry, population genetics theory predicts that 5 
populations should adapt by compensatory mutations when the cost of resistance is large, while 6 
generally beneficial mutations should drive adaptation when the cost of resistance is small.  We tested 7 
this prediction by determining the genomic mechanisms underpinning adaptation to antibiotic-free 8 
conditions in populations of the pathogenic bacterium Pseudomonas aeruginosa that carry costly 9 
antibiotic resistance mutations. Whole-genome sequencing revealed that populations founded by high-10 
cost rifampicin-resistant mutants adapted via compensatory mutations in three genes of the RNA 11 
polymerase core enzyme, whereas populations founded by low-cost mutants adapted by generally 12 
beneficial mutations, predominantly in the quorum sensing transcriptional regulator gene lasR. Even 13 
though the importance of compensatory evolution in maintaining resistance has been widely 14 
recognised, our study shows that the roles of general adaptation in maintaining resistance should not 15 
be underestimated and highlights the need to understand how selection at other sites in the genome 16 
influences the dynamics of resistance alleles in clinical settings.  17 
 
Introduction 
The evolution of antibiotic resistance in pathogenic bacteria is typically accompanied by fitness costs 18 
that are expressed in terms of reduced growth rate, competitive ability and virulence
1-3
. Fitness costs 19 
generate selection against resistance when pathogen populations encounter antibiotic-free 20 
environments, as occurs during transmission between hosts or when antibiotic use is discontinued. 21 
Since exposure to high doses of antibiotic is transient, resistance will only be maintained in the long 22 
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term if resistant populations can evolve adaptations that offset the cost of resistance. Therefore, 23 
understanding the mechanisms that allow resistant bacterial populations to evolve increased fitness is 24 
of fundamental importance to understanding the long-term maintenance of resistance in pathogenic 25 
bacteria.  26 
One possible mechanism through which bacteria can overcome the cost of resistance is by acquiring 27 
compensatory mutations that reduce or eliminate the fitness costs associated with resistance alleles by 28 
recovering the functional defects associated with resistance mutations4-9. Alternatively, it is possible 29 
for antibiotic resistant populations to overcome the fitness cost of resistance by acquiring generally 30 
beneficial mutations that increase fitness without offsetting the cost of resistance per se. Unlike 31 
compensatory mutations, generally beneficial mutations contribute to an increase in fitness regardless 32 
of the genetic background in which they arise
10,11
. In this scenario, resistant populations overcome the 33 
cost of resistance by adapting to general environmental conditions, such as nutrient availability and 34 
the presence of stressors. The dominant view that has emerged from studies of the long-term 35 
evolution of antibiotic resistant populations is that adaptation to the cost of resistance is driven by 36 
compensatory mutations
1,2,12-14
. Compensatory mutations have been identified in clinical pathogen 37 
populations, especially M. tuberculosis15-17, and compensatory adaptation has emerged as a central 38 
explanation for the long-term maintenance of resistance in pathogen populations
3
.  39 
Although compensatory mutations have been identified in a wide range of systems, the fact that 40 
resistant populations can also evolve by generally beneficial mutations that increase fitness 41 
irrespective of antibiotic resistance is far less frequently mentioned in current discussions of antibiotic 42 
resistance evolution. It has been estimated that there are on average 12 possible compensatory 43 
mutations per deleterious mutation in bacteria18, and the rate of compensatory mutation should 44 
therefore be on the order of 12 sites/genome x 9 x 10
-11
 mutations per site per generation under 45 
laboratory conditions19, which corresponds to ≈1 x 10-9 per genome per generation. On the other hand, 46 
generally beneficial mutations have been estimated to occur at a rate between 1 x 10-8 and 1 x 10-5 per 47 
genome per generation under laboratory conditions, which is 10 to 10 000 times higher than our crude 48 
estimate of the rate of compensatory mutation20-23. This asymmetry suggests that, all else being equal, 49 
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generally beneficial mutations are expected to contribute more towards adaptation in antibiotic 50 
resistant populations than compensatory mutations do.  51 
However, adaptation in asexual populations is driven by a small minority of mutations with relatively 52 
large benefits that overcome stochastic drift and competition from rival beneficial mutations due to 53 
clonal interference20,22,24,25. Compensatory mutations are therefore expected to make a 54 
disproportionately large contribution to adaptation when they are associated with large fitness benefits 55 
relative to generally beneficial mutations. Since compensatory adaptation directly recovers the 56 
functional defects associated with resistance mutations
5,7,8,26
, compensatory mutations should confer 57 
large fitness benefits in populations carrying very costly resistance mutations. However, the fitness 58 
benefits associated with compensatory mutations are expected to be small in populations carrying 59 
low-cost mutations. This population genetic framework predicts that the likelihood of adaptation by 60 
compensatory mutations should increase with the cost of resistance
27
. Crucially, studies of evolution 61 
in antibiotic resistant populations have largely focussed on adaptation in populations that carry very 62 
costly resistance mutations
6,28-32
. We postulate that the roles played by general adaptation in 63 
eliminating the fitness cost of antibiotic resistance are greater than currently thought.  64 
To test the hypothesis that high fitness costs promote evolution by compensatory adaptation, we 65 
allowed populations of 8 isogenic rifampicin-resistant isolates of the opportunistic pathogen P. 66 
aeruginosa that carry different fitness costs, as well as their rifampicin-sensitive ancestor, to evolve 67 
for 300 generations in an antibiotic-free rich medium. Extensive whole-genome sequencing was used 68 
to systematically identify compensatory mutations and generally beneficial mutations in evolved 69 
endpoint populations. 70 
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Results & Discussion 
Evolved rifampicin-resistant mutants recover from the fitness cost of resistance 71 
To study adaptation to the cost of rifampicin resistance, we allowed 3 independently propagated 72 
populations of 8 different rifampicin-resistant rpoB mutants that carried different fitness costs to 73 
evolve in a rifampicin-free culture medium for 300 generations. Fitness varied considerably between 74 
the rifampicin-resistant mutants that were used to initiate the selection experiment (Figure 1: one-way 75 
ANOVA, F7,16 = 4.66, P = 0.0052). Fitness increased over the course of the selection experiment 76 
(paired t-test, t7 = 5.47, P = 0.0009), and the fitness of the evolved populations was very similar to 77 
that of the rifampicin-sensitive ancestral strain that the resistant mutants were evolved from. These 78 
results clearly demonstrate that selection in the absence of antibiotics can rapidly eliminate the 79 
substantial fitness cost that is associated with rifampicin resistance for a range of rpoB mutations.   80 
 
Testing for compensatory adaptation using whole-genome sequencing 81 
To determine the genetic basis of adaptation in antibiotic resistant populations, we performed whole-82 
genome sequencing on 3 randomly selected colonies isolated from each evolved endpoint population 83 
(Table 1, Electronic Supplementary Material: 8 populations * 3 populations/mutant * 3 84 
isolates/population = 72 isolates). As a control experiment, we also sequenced the genomes of 85 
evolved isolates from rifampicin-sensitive ancestral populations that were evolved for the same 86 
number of generations (Table 2, Electronic Supplementary Material: 12 populations * 3 87 
isolates/population = 36 isolates). Non-synonymous SNPs (single-nucleotide polymorphisms) and 88 
short indel (insertion and deletion) mutations of <1 kb in protein-coding regions were the most 89 
common forms of mutations that we identified. Silent and intergenic mutations were found at low 90 
frequencies, as were large deletions and duplications spanning more than 1 gene.  91 
The mutations that we identified may include beneficial, neutral or mildly deleterious mutations. 92 
Parallel evolution provides a hallmark of genes that are under strong positive selection33-36, and we 93 
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therefore focused our analysis on genes in which we detected parallel evolution. In our study, parallel 94 
evolution in a particular gene can be demonstrated either by mutations in different populations or by 95 
different mutations within the same endpoint population. Our results broadly indicate that such 96 
parallel evolution was very common in both the evolved resistant and control populations. Amongst 97 
the resistant mutant populations (Figure 2), five genes contained 69% of all mutations that were 98 
detected in the sequenced endpoint isolates evolved from the rifampicin-resistant mutants (highlighted 99 
in blue), while five genes covered 75% of all mutations found in the evolved control populations 100 
(highlighted in red).   101 
Since compensatory mutations interact epistatically with resistance mutations to recover fitness
26,31,37
, 102 
we expected compensatory mutations to be found in evolved resistant populations, but not in 103 
rifampicin-sensitive ancestral populations. Previous studies have shown that second-site mutations in 104 
RNA polymerase subunits (rpoA, rpoB and rpoC) can compensate for the cost of rifampicin 105 
resistance5,7,16,26. Consistent with this, we found 9 independently evolved point mutations in these 106 
RNA polymerase genes amongst the resistant populations, but no RNA polymerase mutations were 107 
detected in the evolved control populations. Interestingly, one of the rpoB mutations represents a 108 
reversion mutation that swept to fixation in a population that was initiated by the H531R mutant. The 109 
reversion mutation restored the rifampicin-sensitive phenotype, which constitutes an evolutionary 110 
reversal of antibiotic resistance. Several lines of evidence suggest that the remaining RNA polymerase 111 
mutations are compensatory mutations rather than generally beneficial mutations. First, the intragenic 112 
second-site mutations in rpoB found in this study (E528D, H531C and N573S) are known to recover 113 
the reductions in transcriptional efficiency and fitness costs associated with the original rpoB 114 
mutations5. Second, we observed three independent examples of parallel evolution in rpoB at an 115 
amino acid level. An additional mutation in the same codon as the original rpoB mutations H531R 116 
and H531Y can result in a common amino acid substitution H531C, which was observed in two 117 
populations founded by H531R and one population founded by H531Y (Table 1, Electronic 118 
Supplementary Material). H531C can offset the fitness cost of the original rpoB mutations without 119 
altering the rifampicin resistance phenotype38. 120 
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To test the hypothesis that low fitness costs constrain compensatory adaptation, we tested for a 121 
negative correlation between the frequencies of RNA polymerase mutations and the initial cost 122 
associated with each rpoB mutation (Figure 3). In support of our hypothesis, we found a significant 123 
negative correlation between the number of compensatory mutations per genome and the initial cost 124 
associated with resistance (Spearman’s rank correlation: ρ = -0.786, r2 = 0.618, F1, 6 = 9.72, P = 125 
0.0206). Almost all isolates from populations that were founded by very costly resistance mutants, 126 
such as H531R and H531Y, carry compensatory mutations, whereas no compensatory mutations were 127 
found in populations that were founded by low-cost resistance mutations such as S536F.  128 
 
Adaptation in antibiotic resistant populations is dominated by generally beneficial mutations 129 
Although we found evidence for compensatory adaptation when the cost of resistance was large, the 130 
dominant genetic mechanism of adaptation in antibiotic resistant populations was mutations in lasR, a 131 
key transcriptional regulator gene involved in quorum sensing39,40. 71% of all endpoint populations 132 
founded by resistant mutants had at least one sequenced isolate with mutations in lasR. There was also 133 
a high diversity of mutations in lasR, which include 26 independently evolved SNPs and short indel 134 
mutations, as well as 4 independent large deletions (> 2 kb) affecting lasR and adjacent genes. These 135 
mutations are thought to disrupt LasR function and result in quorum sensing deficiency
41-45
. For 136 
example, the missense mutation A231V, which was observed in two independent populations founded 137 
by the rpoB mutant Q518R, is known to disrupt LasR functions and quorum-sensing regulated 138 
phenotypic traits
41
. Mutations in lasR led to increased fitness in rpoB mutants (Figure S1, Electronic 139 
Supplementary Material). In agreement with this, numerous studies have shown that P. aeruginosa 140 
populations adapt to novel environments through the loss of LasR function42-46. 141 
lasR mutations were also detected in the evolved control populations (Table 2, Electronic 142 
Supplementary Material), confirming that lasR mutations were not compensatory. More specifically, 143 
three independent lasR mutations we observed are known to compromise LasR function by 144 
eliminating the start codon (M1I), deleting the lasR promoter region
47
 or preventing LasR multimer 145 
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formation via the P74L mutation48. However, the proportion of control populations that had at least 146 
one sequenced isolates with lasR mutations (33%) was lower compared to that of resistant populations 147 
(71%), so it remains to be understood why such discrepancies exist between the resistant and control 148 
populations. 149 
 
The evolutionary dynamics of general and compensatory adaptation  150 
To better understand the conflict between compensatory adaptation and general adaptation, we studied 151 
the dynamics of adaptation by sequencing a time series of isolates from a subset of our selection lines. 152 
We focused on populations in which both generally beneficial mutations and compensatory mutations 153 
were identified (Table 1, Electronic Supplementary Material). The co-occurrence of generally 154 
beneficial mutations and compensatory mutations implies that these populations are likely to provide 155 
direct insights into the outcome of competition between these two classes of beneficial mutations. 156 
Based on the sequencing results, we constructed the evolutionary history for these four populations 157 
(Figure 4). The key insight that emerged from our phylogenetic inference was that general adaptation 158 
tends to precede compensatory adaptation. In three of the four populations, general adaptation initially 159 
occurred through the spread of lasR mutations during the first 24 days of the experiments (Panels B-160 
D, Figure 4). Successful lasR mutants then acquired compensatory mutations in RNA polymerase 161 
genes, which began to increase to detectable frequency by the end of the experiment. In the H531Y-A 162 
population (Panel A, Figure 4), initial adaptation was dominated by the spread of mutations in the 163 
gacA gene. GacS/GacA modulates the expression of more than 500 genes of the RsmA regulon and is 164 
indirectly involved in the regulation of quorum sensing49-51. Subsequently, isolates carrying 165 
compensatory mutations in the rpoB gene also began to increase to detectable frequency by day 30. 166 
Several factors are likely to have favoured this repeatable evolutionary dynamic of general adaptation 167 
followed by compensatory adaptation. We detected a vast diversity of lasR mutations, suggesting that 168 
any mutation that disrupts LasR production and the quorum sensing phenotype is beneficial under 169 
these experimental conditions. In contrast, we found a relatively small number of compensatory 170 
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mutations in RNA polymerase, which supports the idea that compensatory mutations are rare52. This 171 
asymmetry is illustrated by the observation that the frequency of repeated independent mutations in 172 
rpoB (3/7) was much higher than that in lasR (1/30) amongst the resistant populations. lasR mutations 173 
also confer large fitness benefits. For example, 3 double mutants that carry single lasR mutations in 174 
addition to their original rpoB mutations, showed an increased fitness of between 15.6% and 32.3% 175 
(Figure S1, Electronic Supplementary Material). This suggests that the fitness benefit associated with 176 
lasR mutations was likely to be comparable to, or greater than, the benefit associated with 177 
compensatory mutations, except when the cost of resistance was very large. 178 
Surprisingly, we found that the control populations often carried mutations in genes that were not 179 
mutated in resistant populations (Figure 2), including wspA and wspF from the wsp operon (n = 9), 180 
dipA (n = 12), as well as morA (n = 2). The absence of wspA/wspF, dipA and morA mutations in the 181 
resistant populations raised the possibility that the fitness benefit conferred by these mutations could 182 
be contingent on the absence of rpoB mutations (sign epistasis)53. To test this hypothesis, we 183 
measured the fitness of isolates carrying rpoB mutations with dipA or morA mutations and found that 184 
dipA and morA mutations were beneficial in the presence of rpoB mutations (Heilbron et al., in 185 
preparation), implying that sign epistasis cannot explain the absence of mutations in these genes in the 186 
evolved resistant isolates. It is conceivable that the different amounts of time spent by the various 187 
strains in the stationary phase could have contributed to these differences in the mutational spectrum.  188 
 
Conclusion 189 
The idea that compensatory adaptation eliminates the cost of resistance and allows resistance alleles 190 
to effectively persist in bacterial populations has been extensively studied in evolutionary models of 191 
antibiotic resistance
2,3,13,54-56
. Here we examine the underlying genomic basis of adaptation in 192 
rifampicin-resistant populations of the pathogenic bacterium P. aeruginosa. Although rifampicin-193 
resistant populations quickly evolved to overcome their initial fitness cost, compensatory mutations 194 
were only fixed in populations founded by highly costly resistant mutants. Importantly, many studies 195 
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of evolution in antibiotic resistant populations tend to focus on evolution in populations carrying very 196 
costly resistance mutations6,28-32. Our results suggest that the role of generally beneficial mutations in 197 
overcoming the fitness cost of resistance may be more important than currently thought. However, 198 
given the functional diversity of antibiotic resistance mechanisms, more insight into the conflicts 199 
between these two types of mutations could be gleaned by performing experimental evolution studies 200 
using antibiotic-resistant mutants that carry other types of resistance mutations. 201 
Although compensatory adaptation provides a more direct solution to the cost of resistance, two 202 
constraints are likely to restrict compensatory evolution. First, generally beneficial mutations are more 203 
common than compensatory mutations. While compensatory mutations usually occur in the same 204 
protein or pathway as antibiotic resistance mutations do4,52, generally beneficial mutations are 205 
expected to occur at many different sites in the genome. In our study, this asymmetry is highlighted 206 
by the rarity of repeated independent mutations in genes involved in general adaptation, notably in 207 
lasR, versus the higher frequency of repeated nucleotide substitutions in rpoB, which was involved in 208 
compensatory adaptation. Second, generally beneficial mutations can have large effects on fitness that 209 
surpass those associated with compensatory mutations (Figure S1, Electronic Supplementary 210 
Material). We argue that compensatory adaptation tends to occur when the cost of resistance was 211 
large, because compensatory mutations provide very large fitness benefits in populations carrying 212 
costly resistance mutations. 213 
Given that the spread of compensatory mutations can be delayed by the spread of generally beneficial 214 
mutations due to clonal interference, selection for compensatory adaptation will be relatively 215 
ineffective under conditions where selection at other sites in the genome is strong. A number of 216 
important selective forces are likely to exert strong and recurrent selective pressure on populations of 217 
bacterial pathogens, such as antibiotic use
57,58
, bacteriophage
59
 and the immune system
60
, suggesting 218 
that compensatory adaptation may be difficult to acquire in clinical settings. These constraints are 219 
probably especially important in opportunistic pathogens, because they are essentially invading a 220 
novel niche that imposes distinct selective pressures when they establish infections in human 221 
hosts35,61,62. In this respect, it is interesting to note that the best-characterised example of 222 
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compensatory adaptation in a clinical setting, rifampicin resistance in M. tuberculosis7,15,16, comes 223 
from an obligate pathogen that is well adapted to life in human hosts63.  224 
Whole-genome sequencing is now being used extensively to study the population biology of bacterial 225 
pathogens, and it is often thought that mutations that are found in antibiotic resistant isolates are 226 
compensatory mutations15,58,64-66. Although there are some excellent examples of compensatory 227 
adaptation in clinical pathogens
6,15,16,67-69
, it is also apparent that compensatory evolution is not 228 
ubiquitous56. Our study highlights some of the obstacles to evolution by compensatory mutations, but 229 
their consequences remain unclear. On the one hand, it is possible that rapid adaptation by generally 230 
beneficial mutations effectively eliminates selection against antibiotic resistant pathogen lineages. In 231 
this scenario, resistance alleles continue to carry a cost, but selection against resistant lineages is 232 
offset by the beneficial mutations carried at other sites in the genome. Importantly, antibiotic use 233 
results in a large increase in the population size of antibiotic resistant lineages, suggesting that they 234 
should enjoy an increased likelihood of acquiring generally beneficial mutations relative to sensitive 235 
strains that are suppressed by antibiotic use. Compensatory mutations interact epistatically with 236 
resistance mutations such that the loss of resistance mutations becomes deleterious once 237 
compensatory mutations have been acquired. By delaying the spread of compensatory mutations, it is 238 
possible that generally beneficial mutations increase the window of opportunity for reversion to 239 
antibiotic sensitivity. It is hoped that future work will shed light on the roles that selection for 240 
generally beneficial mutation plays in the maintenance of resistance.  241 
 
Materials & Methods 
Selection Experiment 242 
The eight rifampicin-resistant rpoB mutants used in the selection experiment were evolved from the 243 
rifampicin-sensitive PAO1::mini-Tn7-pLAC-lux ancestral strain using a fluctuation test
5
. All strains 244 
were streaked on M9KB agar plates70 and incubated overnight at 30°C. On the next day, 3 245 
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independent colonies per rpoB mutant strain were randomly selected for propagating 3 independent 246 
populations (denoted A-C) during the selection experiment. 1 ml of M9KB liquid culture medium70 247 
was inoculated with a colony in the absence of rifampicin. The bacterial cultures were incubated 248 
overnight with shaking (225 rpm) at 30°C. On the next day, 1 µl of each overnight culture was diluted 249 
1000-fold in fresh M9KB medium and incubated overnight under the same experimental conditions. 250 
The serial transfer was repeated for 30 consecutive days, or approximately 300 generations. Glycerol 251 
stocks of all populations were prepared on the 18th, 24th and 30th (final) days of the selection 252 
experiment.  In a separate set of control experiment, 12 independent colonies of the rifampicin-253 
sensitive ancestral strain were randomly selected for propagating 12 independent populations (denoted 254 
A-L) using the same experimental procedures as described above. 255 
 
Competitive fitness assay 256 
The competitive fitness of the endpoint populations of each of the propagated populations was 257 
quantified relative to the rifampicin-sensitive ancestral strain as previously described5. Briefly, 258 
overnight cultures of the endpoint populations, the PAO1::mini-Tn7-pLAC-lux ancestral strain and a 259 
GFP-tagged derivative strain of PAO1 were diluted 1:10 in M9KB medium and re-grown to early 260 
exponential phase at 30°C with continuous shaking (225 rpm). Each non-fluorescent strain was mixed 261 
with the GFP-tagged strain, diluted 200-fold in M9KB medium and incubated in Nunc 96-well 262 
microplates (Thermo Scientific, USA) at 30°C overnight for approximately 24 hours with continuous 263 
shaking. The proportion of fluorescent and non-fluorescent cells in each co-culture was determined 264 
using an Accuri C6 flow cytometer (BD Biosciences, USA) before and after the incubation. The 265 
competitive fitness of each non-fluorescent strain was calculated as the ratio of population doublings 266 
of each endpoint population relative to the GFP-tagged control strain it was competing against71. The 267 
relative competitive fitness of the endpoint populations was obtained by standardising their 268 
competitive fitness to that of the rifampicin-sensitive ancestral strain within each set of competition 269 
experiments. Three biological and three technical replicates of each strain were assayed for each 270 
endpoint population. 271 
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To demonstrate that lasR mutations are beneficial under the same conditions of the selection 272 
experiment, the competitive fitness of three evolved rifampicin-resistant isolates that carried different 273 
lasR mutations and the initial rpoB mutant strains was determined relative to the rifampicin-sensitive 274 
ancestral strain using a modified version of the competition assays, in which all strains were re-grown 275 
to exponential phase and co-cultured overnight with the GFP-tagged control strain in 5 ml Falcon 276 
tubes (BD Biosciences, USA) using exactly the same growth conditions as those under which the 277 
selection experiment was carried out. 278 
 
Whole-genome sequencing 279 
The initial rpoB mutants and the endpoint populations of the selection experiment were streaked on 280 
M9KB agar plates and incubated overnight at 30°C. On the next day, three colonies of each 281 
population were randomly selected to inoculate M9KB liquid medium incubated at 30°C with shaking 282 
overnight. Genomic DNA was extracted using the DNeasy Blood & Tissue Kit (QIAGEN, 283 
Netherlands) according to the manufacturer’s protocol. The twelve initial isolates of the rifampicin-284 
sensitive ancestral strain and the three randomly selected colonies from the twelve endpoint 285 
populations, which were evolved from these initial isolates during the control experiment, were 286 
prepared for whole-genome sequencing using the same procedures.  287 
To search for evidence of clonal interference in rpoB mutant populations, six random isolates from 288 
the 18th and 24th days of the selection experiment were selected for whole-genome sequencing from 289 
four selected rpoB mutant populations (H531Y-A, Q518L-C, Q518R-B and Q518R-C) using the same 290 
procedures as described above. Three additional random isolates from the four endpoint populations 291 
were whole-genome sequenced to obtain a total of six isolates for each of the three time points 292 
(excluding an isolate from the endpoint population of Q518R-C, which was not successfully 293 
sequenced). 294 
Paired-end whole-genome sequencing with read length of 100 bp was performed using the HiSeq  295 
2000 Sequencing System (Illumina, USA). The average coverage was 44.1x (median coverage: 296 
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43.5x). Variants were identified using an experimentally validated in-house pipeline71,72. The initial 297 
rpoB mutant isolates were found to have the same genetic background, with the exception of the 298 
specified mutations in rpoB. We discarded mutations that were already present in all the initial 299 
isolates with respect to the P. aeruginosa PAO1 reference genome, analyzing only those mutations 300 
that accumulated throughout the selection experiment. 301 
 
Statistics 302 
All statistical analyses were performed using JMP Software Version 11 (SAS, USA). Unless 303 
otherwise stated, all statistical tests are two-tailed, and the level of significance is 0.05. The degrees of 304 
freedom are reported as subscripts next to the test statistics.  305 
 
Data Availability 
Whole-genome sequencing data are available at the European Nucleotide Archive: 306 
 http://www.ebi.ac.uk/ena/data/view/PRJEB11978 307 
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Figure Legends 
Figure 1. Adaptation to the cost of rifampicin resistance 322 
This figure shows the competitive fitness (mean ± s.e; n = 3) of the eight rpoB mutants used to found 323 
the selection experiments (blue diamonds) and the average fitness of three endpoint populations (red 324 
squares) evolved from each rpoB mutant. The rpoB mutations carried by the rifampicin-resistant 325 
mutants are specified in the names assigned to the mutants. The relative fitness of all endpoint 326 
populations converged towards that of the rifampicin-sensitive ancestral strain (standardised to a 327 
value of 1). In all cases, the average relative fitness of the endpoint populations showed a significant 328 
increase compared to that of the initial rpoB mutant (two-sample t-test, P < 0.05). 329 
 
Figure 2. Targets of selection 330 
In the frequency distribution of genes that acquired mutation(s) in at least two independently evolved 331 
endpoint populations, a high degree of parallel evolution can be observed in both the rifampicin-332 
resistant and control populations. At the same time, a distinct difference in the spectrum of genes that 333 
were most frequently mutated can also be observed.  334 
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Figure 3. High fitness costs drive compensatory adaptation in rifampicin-resistant populations 335 
of P. aeruginosa 336 
This graph shows the number of compensatory mutations in RNA polymerase per evolved isolate 337 
(mean ± s.e; n = 3) as a function of fitness cost associated with the eight rifampicin resistance 338 
mutations (mean ± s.e; n = 3). We included the reversion mutation in this analysis, because it is an 339 
adaptation to the cost of rifampicin resistance. The mean number of compensatory mutations per 340 
isolate increases with the cost of resistance, as judged by a Spearman’s rank-order correlation (P < 341 
0.05). 342 
 
Figure 4: Clonal interference constrains compensatory adaptation  343 
A schematic diagram representing the phylogeny inferred for six randomly selected isolates sampled 344 
from the 18
th
, 24
th
 and 30
th
 (final) days for four populations in which the co-occurrence of generally 345 
beneficial mutations and compensatory mutations was detected in the endpoint populations. Circles 346 
represent the observed genotypes, and the diameter of a circle indicates the frequency of that isolate in 347 
the population (n = 1, 2 or 3). Red circles denote isolates carrying compensatory mutations, while 348 
black circles denote isolates carrying generally beneficial mutations but not compensatory mutations. 349 
Each thin arrow represents the acquisition of one or more additional mutations with respect to the 350 
previous genotype. Mutations carried by individual isolates are shown in text, with newly acquired 351 
mutations in blue and previously acquired mutations in black.  352 
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Figure 1. Adaptation to the cost of rifampicin resistance  
This figure shows the competitive fitness (mean ± s.e; n = 3) of the eight rpoB mutants used to found the 
selection experiments (blue diamonds) and the average fitness of three endpoint populations (red squares) 
evolved from each rpoB mutant. The rpoB mutations carried by the rifampicin-resistant mutants are 
specified in the names assigned to the mutants. The relative fitness of all endpoint populations converged 
towards that of the rifampicin-sensitive ancestral strain (standardised to a value of 1). In all cases, the 
average relative fitness of the endpoint populations showed a significant increase compared to that of the 
initial rpoB mutant (two-sample t-test, P < 0.05).  
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Figure 2. Targets of selection  
In the frequency distribution of genes that acquired mutation(s) in at least two independently evolved 
endpoint populations, a high degree of parallel evolution can be observed in both the rifampicin-resistant 
and control populations. At the same time, a distinct difference in the spectrum of genes that were most 
frequently mutated can also be observed.  
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Figure 3. High fitness costs drive compensatory adaptation in rifampicin-resistant populations of P. 
aeruginosa  
This graph shows the number of compensatory mutations in RNA polymerase per evolved isolate (mean ± 
s.e; n = 3) as a function of fitness cost associated with the eight rifampicin resistance mutations (mean ± 
s.e; n = 3). We included the reversion mutation in this analysis, because it is an adaptation to the cost of 
rifampicin resistance. The mean number of compensatory mutations per isolate increases with the cost of 
resistance, as judged by a Spearman’s rank-order correlation (P < 0.05).  
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Figure 4: Clonal interference constrains compensatory adaptation  
A schematic diagram representing the phylogeny inferred for six randomly selected isolates sampled from 
the 18th, 24th and 30th (final) days for four populations in which the co-occurrence of generally beneficial 
mutations and compensatory mutations was detected in the endpoint populations. Circles represent the 
observed genotypes, and the diameter of a circle indicates the frequency of that isolate in the population (n 
= 1, 2 or 3). Red circles denote isolates carrying compensatory mutations, while black circles denote isolates 
carrying generally beneficial mutations but not compensatory mutations. Each thin arrow represents the 
acquisition of one or more additional mutations with respect to the previous genotype. Mutations carried by 
individual isolates are shown in text, with newly acquired mutations in blue and previously acquired 
mutations in black.  
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